These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 31810606

  • 21. Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
    Pan J, Li X, Wu W, Xue M, Hou H, Zhai W, Chen W.
    Cancer Lett; 2016 Nov 01; 382(1):64-76. PubMed ID: 27591936
    [Abstract] [Full Text] [Related]

  • 22. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer.
    Wang SH, Zhang WJ, Wu XC, Weng MZ, Zhang MD, Cai Q, Zhou D, Wang JD, Quan ZW.
    J Cell Mol Med; 2016 Dec 01; 20(12):2299-2308. PubMed ID: 27420766
    [Abstract] [Full Text] [Related]

  • 23. Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine.
    Yang C, Xu M, Shen HJ, Zhu HY, Li F, He M, Chen T, Wang J, Shi WJ, Ji F.
    Int J Clin Exp Pathol; 2014 Dec 01; 7(2):521-8. PubMed ID: 24551272
    [Abstract] [Full Text] [Related]

  • 24. The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis.
    Sun Y, Wang P, Yang W, Shan Y, Zhang Q, Wu H.
    Cancer Biol Ther; 2019 Dec 01; 20(6):729-739. PubMed ID: 30915884
    [Abstract] [Full Text] [Related]

  • 25. Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy.
    Cai Q, Wang S, Jin L, Weng M, Zhou D, Wang J, Tang Z, Quan Z.
    Mol Cancer; 2019 Apr 05; 18(1):82. PubMed ID: 30953511
    [Abstract] [Full Text] [Related]

  • 26. Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α.
    Gao H, Xie J, Peng J, Han Y, Jiang Q, Han M, Wang C.
    Exp Cell Res; 2015 Mar 15; 332(2):236-46. PubMed ID: 25499970
    [Abstract] [Full Text] [Related]

  • 27. Low expression of TRAF3IP2-AS1 promotes progression of NONO-TFE3 translocation renal cell carcinoma by stimulating N6-methyladenosine of PARP1 mRNA and downregulating PTEN.
    Yang L, Chen Y, Liu N, Shi Q, Han X, Gan W, Li D.
    J Hematol Oncol; 2021 Mar 19; 14(1):46. PubMed ID: 33741027
    [Abstract] [Full Text] [Related]

  • 28. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma.
    Ma F, Wang SH, Cai Q, Jin LY, Zhou D, Ding J, Quan ZW.
    Biomed Pharmacother; 2017 Apr 19; 88():863-869. PubMed ID: 28178615
    [Abstract] [Full Text] [Related]

  • 29. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
    Liang J, Tian XF, Yang W.
    World J Gastroenterol; 2020 Apr 07; 26(13):1474-1489. PubMed ID: 32308348
    [Abstract] [Full Text] [Related]

  • 30. Long non-coding RNA TMPO-AS1 promotes cell proliferation, migration, invasion and epithelial-to-mesenchymal transition in gallbladder carcinoma by regulating the microRNA-1179/E2F2 axis.
    Sui Z, Sui X.
    Oncol Lett; 2021 Dec 07; 22(6):855. PubMed ID: 34777589
    [Abstract] [Full Text] [Related]

  • 31. The transcribed ultraconserved element uc.51 promotes the proliferation and metastasis of breast cancer by stabilizing NONO.
    Shi X, Huang X, Chen R, Li Y, Xu Y, Zhang W, Zhu Q, Zha X, Wang J.
    Clin Exp Metastasis; 2021 Dec 07; 38(6):551-571. PubMed ID: 34714466
    [Abstract] [Full Text] [Related]

  • 32. RNA-binding protein NONO contributes to cancer cell growth and confers drug resistance as a theranostic target in TNBC.
    Kim SJ, Ju JS, Kang MH, Eun JW, Kim YH, Raninga PV, Khanna KK, Győrffy B, Pack CG, Han HD, Lee HJ, Gong G, Shin Y, Mills GB, Eyun SI, Park YY.
    Theranostics; 2020 Dec 07; 10(18):7974-7992. PubMed ID: 32724453
    [Abstract] [Full Text] [Related]

  • 33. Silencing of long non-coding RNA FOXD2-AS1 inhibits the progression of gallbladder cancer by mediating methylation of MLH1.
    Gao J, Dai C, Yu X, Yin XB, Liao WJ, Huang Y, Zhou F.
    Gene Ther; 2021 Jun 07; 28(6):306-318. PubMed ID: 32917950
    [Abstract] [Full Text] [Related]

  • 34. Long non-coding RNA GAS6-AS1 acts as a ceRNA for microRNA-585, thereby increasing EIF5A2 expression and facilitating hepatocellular carcinoma oncogenicity.
    Ai J, Sun J, Zhou G, Zhu T, Jing L.
    Cell Cycle; 2020 Apr 07; 19(7):742-757. PubMed ID: 32089066
    [Abstract] [Full Text] [Related]

  • 35. Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis.
    Gu N, Wang X, Di Z, Xiong J, Ma Y, Yan Y, Qian Y, Zhang Q, Yu J.
    Aging (Albany NY); 2019 Nov 26; 11(22):10266-10283. PubMed ID: 31770107
    [Abstract] [Full Text] [Related]

  • 36. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
    Shi Y, Fan Y, Hu Y, Jing J, Wang C, Wu Y, Geng Q, Dong X, Li E, Dong D.
    J Cell Mol Med; 2020 Jan 26; 24(1):760-771. PubMed ID: 31762191
    [Abstract] [Full Text] [Related]

  • 37. AFAP1-AS1/Hsa-miR-15a-5p/Bcl-2 Axis is a Potential Regulator of Cancer Cell Proliferation and Apoptosis in Gallbladder Carcinoma.
    Zhu X, Shi C, Hou C.
    Nutr Cancer; 2022 Jan 26; 74(9):3363-3374. PubMed ID: 35404727
    [Abstract] [Full Text] [Related]

  • 38. Mechanisms of verapamil-enhanced chemosensitivity of gallbladder cancer cells to platinum drugs: glutathione reduction and MRP1 downregulation.
    Wang H, Li X, Chen T, Wang W, Liu Q, Li H, Yi J, Wang J.
    Oncol Rep; 2013 Feb 26; 29(2):676-84. PubMed ID: 23229154
    [Abstract] [Full Text] [Related]

  • 39. A Novel Gemcitabine-Resistant Gallbladder Cancer Model Provides Insights into Molecular Changes Occurring during Acquired Resistance.
    Vergara-Gómez L, Bizama C, Zhong J, Buchegger K, Suárez F, Rosa L, Ili C, Weber H, Obreque J, Espinoza K, Repetto G, Roa JC, Leal P, García P.
    Int J Mol Sci; 2023 Apr 14; 24(8):. PubMed ID: 37108401
    [Abstract] [Full Text] [Related]

  • 40. lncRNA DLG1-AS1 promotes cervical cancer cell gemcitabine resistance by regulating miR-16-5p/HDGF.
    Zou MJ, Cheng XR, Liu RF.
    J Obstet Gynaecol Res; 2022 Jul 14; 48(7):1836-1847. PubMed ID: 35388952
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.